In reviewing this series of approximately 150 patients, it is apparent that regression has been produced in so-called solid tumours which was never achieved by systemic chemotherapy. Unfortunately, while some degree of tumour response in the treated territory followed in the majority of cases, this was usually incomplete and seldom long lasting. Furthermore the area of effectiveness of regional treatment was strictly limited by the vascular anatomy as shown by the failure of tumour regression in areas outside the particular capillary bed which could be outlined by intra-arterial dye injection.
Discussion
In reviewing this series of approximately 150 patients, it is apparent that regression has been produced in so-called solid tumours which was never achieved by systemic chemotherapy. Unfortunately, while some degree of tumour response in the treated territory followed in the majority of cases, this was usually incomplete and seldom long lasting. Furthermore the area of effectiveness of regional treatment was strictly limited by the vascular anatomy as shown by the failure of tumour regression in areas outside the particular capillary bed which could be outlined by intra-arterial dye injection.
We thought that these disappointing results might have been influenced by our selection of cases; most patients had hopelessly advanced disease and had usually been subjected to previous surgery and/or irradiation. Indeed, a review of the literature indicates similar results in roughly comparable series (Sullivan 1962 , Hall et al. 1962 .
These considerations lead us to the view that, at present, regional chemotherapy by intraarterial infusion and injection, though possibly a valuable addition to surgery and irradiation in the early case, and a useful palliative measure for the otherwise hopeless case, in no way replaces conventional methods of treatment of localized cancer.
Summary
(1) The results of continuous intra-arterial infusion and intermittent intra-arterial injection of cytotoxic agents in 150 patients are described.
(2) Regional chemotherapy by these techniques has frequently produced tumour regression, but this has seldom been long lasting. Potee (Surgical Unit, St Mary's Hospital, London) In order to avoid the severe local reactions or vascular thrombosis which followed intra-arterial injections of chemotherapeutic agents, such as those described by Cook (1959) and by Ryan et al. (1958) , Creech et al. (1958) introduced techniques whereby the tumour-bearing area of the body was isolated from the systemic circulation, its blood flow being maintained by a pump-oxygenating machine.
By reducing the amount of agent reaching the marrow and gastro-intestinal tract much higher levels could be administered to the tumourbearing area. In addition, when the drug had been mixed in the pump before reaching the arteries, a much higher dosage was possible than with simple intra-arterial injection. Not only is greater total dosage of the drug permissible by this means; but, because the perfused volume is in the order of 20 % of the total blood volume, the concentration of the chemotherapeutic agent in the tumour area is fifteen to twenty times greater than that obtainable by systemic therapy (Henschke & Cole 1961) . Lastly, using the pump-oxygenator it was possible to raise the arterial oxygen tension in the region perfused more than fourfold; because these agents were thought to act in a similar way to X-rays this might increase the vulnerability of the malignant cells (Churchill-Davidson et al. 1957 , Gray 1957 , and experimental evidence was produced that raising the oxygen tension did enhance the effect of these drugs (Krementz et al. 1960 ).
This technique was later extended to patients with widespread malignant deposits, and totalbody perfusion was carried out after removing some of the patient's own marrow for reinfusion later, when the action of the drugs had ceased. By the end of 1959 Creech and his colleagues reported 145 cases which had undergone regional or total-body perfusion, with some regression in about half of them (Creech et al. 1959a ). Others using similar regional techniques have reported the results of treating tumours of the pelvis (Austen et al. 1959 ), brain (Woodhall et al. 1959 ), head and neck (Woodhall et al. 1960) , lungs (Pierpont 1960) , and indeed the whole abdominal viscera and liver (Shingleton et al. 1960 ).
As regional chemotherapy with an extracorporeal circuit developed, the local factors in 'This paper is a revised version of that by Irvine et al. (1962) and Ls printed here by permission of the Editor of the Lancet this regional circulation came under study. Clearly the pressure in this circuit should be less than the systemic blood pressure to discourage leakage into the general circulation. Initially many favoured low flow-rates (Stehlin 1961) , with the object of permitting better mixing of the drug with the tumour by allowing it to remain in the extremity longer on the first circulation. But at low flowrates the low blood pressure in the perfused region may encourage vascular shut-downs, and it seems reasonable to use as high a flow-rate as the venous return will allow, with a pressure only slightly below the systemic pressure. The venous return is very variable, however, in these regional perfusions; and a flow-rate greater than the venous return increases local fluid loss. The effect of temperature was understood from the outset. Since a rise in temperature increases the rate of most metabolic and enzymatic processes, hyperthermia in the perfusion circuit was desirable; and for the same reason systemic hypothermia has been advocated to protect the bone-marrow from any leakage of the drug.
OPERATIVE TECHNIQUE
The operative details of the technique of regional perfusion which we have used have been described elsewhere (Irvine & Noon 1962) . Basically it consists of the cannulation of the artery and vein of the segment to be perfused. Thus in the leg the femoral artery and vein are cannulated; in the arm the axillary artery and vein are used. After insertion of the cannule a tourniquet is applied above them, and the arterial and venous lines are connected to the extracorporeal circulation. When a block dissection is required because of lymphatic metastases, this is done in the standard way, and the perfusion is then performed under the same anxsthetic. Pelvic perfusions are carried out by retrograde cannulation of the lower aorta and vena cava, the cannulx being passed up from the femoral artery and vein. The aorta and vena cava are then occluded above, and thigh tourniquets are applied to the legs. TO 
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The Extracorporeal Circuit The general arrangement of the external circuit is shown in Fig 1. From the venous cannula the blood is drained either by gravity or by a pump to the oxygenator. We have found the disposableplastic-bag oxygenators (produced by Abbott and Baxter) very satisfactory, and at flow-rates of up to 250 ml per min bubbling has not been a problem. From the oxygenator the blood is passed through a second pump, and from there via heatexchanger and filter into the arterial cannula. The temperature is raised because this increases the speed of reaction of the cytotoxic drugs, and the heat-exchanger must be placed close to the arterial cannula or any rise in temperature will not be maintained. The pressure in the external circuit is recorded.
Measurement ofthe Leakage
Twenty ml of a 51Cr-labelled red-cell suspension is injected into the input side of the pump. Fifteen minutes later a sample of blood is taken from the patient's peripheral circulation. The radioactive concentration of the injected red-cell suspension and of the peripheral blood is then determined, and from this the degree of leakage can be calculated. Only when the degree of interchange between the two circulations is known is the final dosage of the cytotoxic drug decided.
Cytotoxic Agents Used
In the studies here reported, with one exception, alkylating agents were used alone. Mustine, or the longer acting phenylalanine mustard (PAM) dissolved in alcohol were the agents used. The ester hydrochloride of PAM was used twice, and on both occasions severe muscle damage was seen at a dosage which had been considered conservative in the alcohol-dissolved PAM. Later animal studies confirmed that the water-soluble ester hydrochloride of PAM is more damaging to normal tissues in the region perfused. Choice ofCytotoxic Agent PAM was the drug used for melanomata as many of them have an increased requirement for tyrosine, and it may be that the structurally related PAM is concentrated in the cells producing melanin. Most of the other tumours were perfused with mustine, and on one occasion mustine and actinomycin D were used in combination.
Dosage ofDrug in RegionalPerfusions
A guide to the total dosage (per kg of total bodyweight) when leakage was limited is:
Administration of the Cytotoxic Drug When the perfusion has been shown to have a steady venous return, the cytotoxic drug is introduced. The dose is always fractionated to avoid too high a concentration, and given in three or four instalments at intervals of ten to fifteen minutes. The later fractions are not injected until the leakage has been finally estimated, and with a large leak the dose is proportionately reduced. The site of injection of these drugs is very important. The injection should be proximal to the arterial pump to encourage mixing before passage into the body.
Duration ofPerfusion
When using shorter acting drugs, like mustine, the perfusion is continued for forty-five minutes. With longer-acting drugs, like PAM, the perfusion lasts about ninety minutes, and at its termination an exchange transfusion is done before a normal circulation is restored. COMPLICATIONS OF REGIONAL PERFUSION These have been general and local. The former have seldom been severe or serious, and local complications have become progressively less frequent with greater experience and more careful dosage.
General Complications Peripheral circulatory collapse: In the first hours following perfusion, signs of a failing circulation may be seen with rise in pulse and fall in blood pressure. This is usually associated with signs of local fluid loss in the perfused part, and the proper treatment is to give plasma, not blood, which may raise the haematocrit. In some cases no great fluid loss is apparent, and it may be that tumour and tissue damage may release substances which are toxic or which increase capillary permeability.
Depression ofplatelets and white-cell count: This occurs in most patients between the fifth and seventh day, even when the leakage is small. The blood picture usually returns to normal within three weeks. Since the fraction of the total dose reaching the general circulation is often too small to produce hemopoietic depression, it may be that some product of tissue damage produces this effect. Occasionally the leucopenia is severe enough to require barrier nursing, and when a large leakage is expected, some of the patient's marrow may be removed for storage before the introduction of the cytotoxic drug, to be reinfused later if required. Rare side-effects: Gastro-intestinal disturbances are occasionally seen. Alopecia, usually temporary, may occur, and sterility in the male may result from damage to the testicles.
Local Complications
Mild aedema may be seen in many cases about twenty-four hours after the perfusion. Wound sepsis: Not infrequently the large wounds required for block dissection of lymph glands before perfusion heal slowly, and wound sepsis certainly seems to be more common.
Rare Local Complications due to Faulty Technique Damage to normal tissues: Erythema and blistering of skin, necrosis of muscle, and nerve damage have all been seen rarely, and only when an excessive dose of the cytotoxic agent was given. The two most serious cases of local tissue damage were associated with the use of the water-soluble PAM ester hydrochloride at the same dosage as PAM. One of these patients had so much muscle damage that amputation was required. The second also had very extensive muscle necrosis with blockage of the renal tubules, and he died of urnmia despite the use of an artificial kidney.
Vascular thrombosis: If the total dose is not fractionated, the initial high concentration of the drug may produce vascular thrombosis in small or even large vessels. If the drugs are instilled at a time when the venous return is poor and there is a hold up in small peripheral vessels, there may be thrombosis in the smaller vessels peripherally at even moderate dosage.
EVIDENCE OF RESPONSE
Many of the tumours perfused have shown no evidence of response, and have continued to proliferate and enlarge. When the tumour is affected the changes seen have varied considerably from case to case, and to some extent they depend on the site of the lesion:
Thus cutaneous melanomata may slowly become flatter and end up as a dark pigmented cicatrix or disappear entirely. Others become completely necrotic, and fluctuation can be detected. They form sloughs, and healing of the resultant depressed ulcer takes place slowly. The subcutaneous tumours may be surrounded by a considerable inflammatory response at the end of the first week, and the tumour may then appear larger. As inflammation resolves the lesion may regress in size; but histological examination at this stage often shows that apparently normal melanoma cells are still present, and the tumour may once more progress at a later date. Again the lesion may continue to diminish in size over many months. In larger solid tumours we have seen peripheral necrosis with a line of separation between normal tissue and tumour edge, and occasionally this has been followed by complete sloughing of the tumours.
Failure to achieve a response does not preclude success with another agent, and what we need is some in vitro test for choosing the cytotoxic drug most likely to damage the tumour presenting for regional perfusion.
CLINICAL SERIES
This report is based on 42 cases which underwent regional perfusion. All the patients have been followed for not less than six months unless they have died. In the majority who are still alive the follow-up is longer than a year. The region perfused and the nature of the tumour are outlined in Table 1 . From this it will be seen that, of the 37 regional perfusions of arm and leg, 32 were for peripheral melanomata; and of the 15 pelvic perfusions 1 was for extensive melanoma of the penis with secondary spread to the groin, and another was for similar spread from a melanoma of vulva. In discussing the results of treatment the 32 cases of malignant melanoma will be considered first because they form the only large single group with a common pathology. The results in the remaining 16 cases with varied pathology will then be described in groups, depending on the type of perfusion. These patients fell into two groups:
Group 1: In this group regional perfusion was used as an adjuvant to orthodox surgical treatment of malignant melanoma. In short, at the time of the excision of the primary tumour, or soon after, the regional lymph glands were excised and a regional perfusion of the limb was carried out. Group 2: In this group adequate surgical excision had been followed by local recurrence, and there were often multiple metastases in the limb and/or secondary deposits in the lymph glands. Table 2 sets out the results achieved in the two groups. Of the 13 patients who underwent regional perfusion at the time of excision of the primary tumour 11 are alive and free of disease. The second group was very varied; the 2 pelvic perfusions with solid infiltrating groin masses are in this group. Many of them had multiple recurrences in the limb after very adequate treatment of the primary tumour, and 14 of the 19 patients had positive nodes in the lymph drainage area; their progress is shown in Table 2. One of the 19 died of (1) Regional perfusion attime of 13 11 1 1 0 primary excision of tumour. <2) Regional perfusion in presence 19 7 5 5 2 of local (often multiple) regional recurrences after excision of primary tumour Fig 2 Case 1 A, recurrent melanomata of leg following surgical excision and regional perfusion. B, four months after the second regional perfusion the melanomata had disappeared intestinal obstruction in the post-operative period. Another died of renal failure secondary to extensive muscle necrosis in the perfused part (this patient had had PAM ester hydrochloride I 5 mg per kg body weight). Of the other 17 patients, 7 have remained free of disease, 5 have again shown evidence of recurrence locally, and 5 have died of the disease. Two of these patients in this second group will be described in more detail.
Case 1 This woman presented with multiple recurrent melanomata in the region of the ankle after local excision. After perfusion with PAM 120 mg they regressed, and histological examination showed the tumours to be partially necrotic. Two months later melanomata had recurred in the same region (Fig 2A) . A second perfusion was carried out (PAM 120 mg), and the recurrent melanomata again responded to therapy. Most of them became necrotic and fluctuant, and at biopsy only liquid debris was found. One remaining tumour overlying the tendo achiflis afterwards slowly regressed and has now disappeared. Fig 2B shows the ankle four months after the second perfusion, and the patient is at present without any obvious evidence of disease. Case 2 A melanoma about 2 cm in diameter was removed from the antero-medial aspect of this patient's midthigh ( Fig 3A) . Within six weeks the tumour had recurred near the operation scar and had reached a dianmeter of 4 cm. After block excision of the groin and regional perfusion with PAM 100 mg, the tumour became completely necrotic ( Fig 3B) and no further disease has appeared in the leg.
REGIONAL PERFUSION OF OTHER TUMOURS Pelvic Perfusions Carcinoma ofcervix: Four patients with extensive pelvic spread were treated. In none was there any really significant evidence of response though severe pain was relieved in 2. Carcinoma ofrectum: Two patients with extensive spread were treated, but there was no evidence of response.
Carcinoma of bladder: One case showed no evidence of response.
Osteoclastoma of pelvis: One patient wit4 an enormous osteoclastoma of ilium showed evidence of good response, both grossly and microscopically.
Carcinoma of vagina, with extensive spread to groin: This patient probably responded to treatment. The secondary deposits in the groin had infiltrated the common femoral artery; and, when these tumours became necrotic after perfusion, uncontrollable bleeding necessitated ligation of the external iliac artery, and later amputation. At necropsy there was no evidence of remaining viable tumour.
Secondary pelvic metastases: One patient with a large solitary ileal metastasis after nephrectomy for hypernephroma was perfused; his pain was strikingly relieved, and the progress of the lesion was arrested for nine months. Eventually he died of generalized disease. Another patient with extensive pelvic bone metastases from a silent carcinoma of bronchus had pelvic perfusion which relieved her intractable pain, but failed to alter the progress of the tumour.
Arm Perfusions
Synovioma of hand: This recurred after primary excision, and perfusion with mustine produced temporary regression of the tumour. Later the disease became generalized and recurred in the hand before death eighteen months later. Fibrosarcoma: A fibrosarcoma of the forearm recurred after local excision. The arm was perfused with mustine, and the recurrence was excised two weeks later. There was no histological evidence of damage, and the tumour has not recurred.
Leg Perfusions
Synovioma of knee: This very large tumour was treated by perfusion with mustine. Histological evidence of tumour necrosis was obtained but the necrotic tumour made the limb unstable and amputation was required. Reticulum cell sarcoma of tibia: This massive tumour was in one of our first perfusion cases, and too large a dose of mustine (90 mg) was given.
Extensive necrosis of limb and tumour followed and amputation was eventually required. Recurrentfibrosarcoma ofleg: This recurrence was treated by perfusion with mustine which had no effect on the course of the disease.
DISCUSSION
Although a wide range of different tumours has been perfused, only in melanomata have objective changes been produced with any frequency. A wider experience of other tumours might have diminished this difference, but others (Creech et al. 1959b ) have also found melanomata apparently more susceptible to such therapy. Does the PAM in fact achieve greater selectivity of drug uptake by the cells of the melanoma, or is it that the smallness of many of these tumours favours a more even uptake of the drug by the tumour cells? Even using PAM on melanomata, the results are very variable. Some patients showed no evidence of response. In others some tumours were unaffected in an area where others became completely necrotic. Why some melanomata should slowly regress while others in the same limb become immediately necrotic is not understood. It is even possible that on occasion these drugs, which are mutagenic, produce some antigenic change in the tumour cells which stimulates an immune response in the host.
With such variations in response in a single limb, a possible objection to the technique of regional perfusion is the limited time to which the tumour is exposed to the drug. If the alkylating agents affect cells in early interphase, others in more advanced stages of mitosis may escape damage, and of course tumours are not homogeneous in thisrespect and all stages of mitosis are often seen. In an attempt to produce synchronous mitosis in an experimental tumour, Ryan et al. (1960) tried colchicine, which prolongs the period of metaphase, before nitrogen-mustard therapy, with apparently better results. Since colchicine does not completely arrest cells at the metaphase, synchronous mitosis would not be achieved by this means; but the approach is an interesting one and worthy of study by more effective drugs. Since we have sometimes seen whole tumours become necrotic, this matter of stage of mitosis may not be often of practical importance. Theoretically, however, infusions through an arterial cannula over a period of ten days might have advantages over regional perfusion, and this method has been used alone or in association with irradiation. It has already given very encouraging results in the treatment of carcinoma of the tongue (Espiner et al. 1962; Irvine 1962, unpublished data; Ryan 1961, personal communication) , and in the treatment of Kaposi's sarcoma with mustine (Cook 1961 ). Was regional perfusion worth while for thesemelanomatous patients? Of the group receiving regional perfusion as an adjuvant to surgery, 11 of the 13 remain clear of the disease, the mean follow-up time in this group being 1-5 years. One cannot say that surgery alone in these 11 cases would definitely have achieved less. Before this matter is settled, much larger numbers of patients will have to undergo regional perfusion at the time of excision of the primary tumour. It is, however, a sound approach. Many of these malignant melanomata arise below the knee or ankle, and lymph drainage from there passes up along the deep veins and is not accessible to surgical excision. Regional perfusion may well reach these deeply spreading cells, and the smaller the malignant-cell groups at the time of perfusion, the more likely is the method to be efficacious.
Of the 19 recurrent melanomata with regional metastases only 7 achieved any useful response and are now walking about with the affected limb apparently free of disease. Little was achieved in the other cases. Might another drug have succeeded? Regional perfusion can be a tedious timeconsuming business involving many people, and in these patients there was no way of predicting the result. If more information were available about the tumour's sensitivity to the cytotoxic agents available, many more profitable perfusions might be seen. The effect of drugs on tumour cells in vitro (Ambrose et al. 1962 , Cobb et al. 1961 , Krementz et al. 1959 , Wright et al. 1957 , tumour implants into the anterior chamber of guinea-pigs (Creech 1961, personal communication) , and enzyme studies (Wolberg & Curreri 1961) have all been tried, and their further evaluation is awaited.
With regional perfusion for tumours other than melanomata the results have been very disappointing, and assay techniques for selecting the most effective cytotoxic agent before perfusion are even more urgently required. However, it must be remembered that, if the action of the alkylating agents is with the deoxyribonucleic acid of cells about to undergo mitosis, the chances of achieving highly selective tumour uptake are limited. Many normal tissues will have mitotic rates as high or higher than the tumour, and selective uptake would require qualitative differences in deoxyribonucleic acid. Greater selectivity of tumour uptake might be achieved if the toxic agent was linked to a radical or substrate of special importance to the tumour cell. Attempts have been made to produce antibodies against tumours with the hope of attaching a cytotoxic agent (Mathe et al. 1958) or uranium compound (Knock 1959) , and thus achieving more selective uptake. This last approach has its own difficulties. Many heterologous antibodies to tumours have cross-reactions with normal tissues (rat Jensen sarcoma), and such antibody itself is not necessarily cytotoxic, and far from slowing it may enhance tumour growth (Kaliss 1958 ).
Yet another approach to selectivity and therefore to increased effectiveness would be the conversion of the cytotoxic agent into a less toxic derivative in the laboratory, which would be reactivated preferentially at the tumour site (Williams 1961) . Mannomustine and cyclophosphamide are such derivates, but good evidence of their increased effectiveness is lacking. However, this approach to cancer chemotherapy is but beginning, and the study of tumour enzymes may yet allow relatively non-toxic compounds to be devised which will be activated at the tumour cells.
All these methods of enhancing the effectiveness of drugs for regional perfusion deserve further study, and new drugs will no doubt be found.
New cytotoxic agents for use in regional chemotherapy must be used with caution. Damage to normal tissues in the region perfused is the limiting factor and toxicity based on marrow depression is no guide to dosage. The two tragedies caused by the use of PAM ester hydrochloride would not have occurred if the dosage had first been determined by regional perfusion of the hind limb in dogs.
